BackTaiwan Liposome Company Overview

Taiwan Liposome Company Other Current Liabilities

Track Taiwan Liposome Company's other current liabilities ($330M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$327.85M
↑ 35.90% YoYΔ $86.61M vs prior year quarter

Peer trimmed avg / median

Loading

Taiwan Liposome Company Other Current Liabilities History

Loading

Taiwan Liposome Company vs. peers: Other Current Liabilities Comparison

Loading

Taiwan Liposome Company Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Taiwan Liposome Company (TLC) FAQ

As of the most recent data (June 2021), TLC shows a other current liabilities of $330M. That compares with $240M in the prior-year period — up 35.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TLC's other current liabilities is now $330M (was $240M) — a 35.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Taiwan Liposome Company is outperforming or lagging.

Tracking TLC's other current liabilities over time shows whether Taiwan Liposome Company is scaling, shrinking, or reshaping that part of the business. The current reading is $330M That compares with $240M in the prior-year period — up 35.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Taiwan Liposome Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $330M) with ownership activity and broader fundamentals.

Taiwan Liposome Company's other current liabilities is $330M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.